Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Clotet, Bonaventura, Dr, Feinberg, Judith, Prof, van Lunzen, Jan, Prof, Khuong-Josses, Marie-Aude, MD, Antinori, Andrea, MD, Dumitru, Irina, MD, Pokrovskiy, Vadim, Prof, Fehr, Jan, MD, Ortiz, Roberto, MD, Saag, Michael, Prof, Harris, Julia, MA, Brennan, Clare, DPT, Fujiwara, Tamio, PhD, Min, Sherene, MD
Published in The Lancet (British edition) (28.06.2014)
Published in The Lancet (British edition) (28.06.2014)
Get full text
Journal Article